Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation

被引：130

作者：

Ang, Estabelle S. M. ^{[2
]}

Yang, Xiaohong ^{[3
]}

Chen, Honghui ^{[3
]}

Liu, Qian ^{[4
]}

Zheng, Ming H. ^{[4
]}

Xu, Jiake ^{[1
]}

机构：

[1] Univ Western Australia, Sch Pathol & Lab Med, QEII Med Ctr, Nedlands, WA 6009, Australia

[2] Univ Western Australia, Sch Dent, Oral Biol Res Lab, Nedlands, WA 6009, Australia

[3] Jinan Univ, Guangzhou Inst Traumat Surg, Affiliated Hosp 4, Coll Med, Guangzhou 510220, Guangdong, Peoples R China

[4] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia

来源：

FEBS LETTERS | 2011年 / 585卷 / 17期

基金：

英国医学研究理事会;

关键词：

Naringin; Osteoclastogenesis; Bone resorption; RANKL; NF-kappa B; INDUCED GENOMIC INSTABILITY; RECEPTOR ACTIVATOR; ENDOTOXIN-SHOCK; PROTEIN-KINASE; MICE; DIFFERENTIATION; LIGAND; SUPPRESSION; INVOLVEMENT; PATHWAY;

D O I：

10.1016/j.febslet.2011.07.046

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Osteolytic bone diseases including osteoporosis are commonly accompanied with enhanced osteoclast formation and bone resorption. Naringin, a natural occurring flavonoid has been found to protect against retinoic acid-induced osteoporosis and improve bone quality in rats. Here, we showed that naringin perturbs osteoclast formation and bone resorption by inhibiting RANK-mediated NF-kappa B and ERK signaling. Naringin suppressed gene expression of key osteoclast marker genes. Naringin was found to inhibit RANKL-induced activation of NF-kappa B by suppressing RANKL-mediated I kappa B-alpha degradation. In addition, naringin inhibited RANKL-induced phosphorylation of ERK. This study identifies naringin as an inhibitor for osteoclast formation and bone resorption, and provides evidence that natural compounds such as naringin might be beneficial as an alternative medicine for the prevention and treatment of osteolysis. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：2755 / 2762

页数：8

共 31 条

[1] Mangiferin Attenuates Osteoclastogenesis, Bone Resorption, and RANKL-Induced Activation of NF-κB and ERK [J].

Ang, Estabelle ;

Liu, Qian ;

Qi, Ming ;

Liu, Hua G. ;

Yang, Xiaohong ;

Chen, Honghui ;

Zheng, Ming H. ;

Xu, Jiake .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (01) :89-97

[2] Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL) [J].

Ang, Estabelle S. M. ;

Zhang, Ping ;

Steer, James H. ;

Tan, Jamie W. -Y. ;

Yip, Kirk ;

Zheng, Ming H. ;

Joyce, David A. ;

Xu, Jiake .

JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (03) :787-795

[3] Caffeic Acid Phenethyl Ester, an Active Component of Honeybee Propolis Attenuates Osteoclastogenesis and Bone Resorption Via the Suppression of RANKL-Induced NF-κB and NFAT Activity [J].

Ang, Estabelle S. M. ;

Pavlos, Nathan J. ;

Chai, Lee Y. ;

Qi, Ming ;

Cheng, Tak S. ;

Steer, James H. ;

Joyce, David A. ;

Zheng, Ming H. ;

Xu, Jiake .

JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 221 (03) :642-649

[4] Abatement by naringin of lomefloxacin-induced genomic instability in mice [J].

Attia, Sabry M. .

MUTAGENESIS, 2008, 23 (06) :515-521

[5] Required and nonessential functions of nuclear factor-kappa B in bone cells [J].

Boyce, BF ;

Xing, L ;

Franzoso, G ;

Siebenlist, U .

BONE, 1999, 25 (01) :137-139

[6] Requirement for NF-κB in osteoclast and B-cell development [J].

Franzoso, G ;

Carlson, L ;

Xing, LP ;

Poljak, L ;

Shores, EW ;

Brown, KD ;

Leonardi, A ;

Tran, T ;

Boyce, BF ;

Siebenlist, U .

GENES & DEVELOPMENT, 1997, 11 (24) :3482-3496

[7] MECHANISM-BASED INACTIVATION OF HUMAN LIVER MICROSOMAL CYTOCHROME-P-450-IIIA4 BY GESTODENE [J].

GUENGERICH, FP .

CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (04) :363-371

[8] U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells [J].

Hotokezaka, H ;

Sakai, E ;

Kanaoka, K ;

Saito, K ;

Matsuo, K ;

Kitaura, H ;

Yoshida, N ;

Nakayama, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47366-47372

[9] Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand [J].

Hsu, HL ;

Lacey, DL ;

Dunstan, CR ;

Solovyev, I ;

Colombero, A ;

Timms, E ;

Tan, HL ;

Elliott, G ;

Kelley, MJ ;

Sarosi, I ;

Wang, L ;

Xia, XZ ;

Elliott, R ;

Chiu, L ;

Black, T ;

Scully, S ;

Capparelli, C ;

Morony, S ;

Shimamoto, G ;

Bass, MB ;

Boyle, WJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3540-3545

[10] Osteopetrosis in mice lacking NF-kappa B1 and NF-kappa B2 [J].

Iotsova, V ;

Caamano, J ;

Loy, J ;

Yang, Y ;

Lewin, A ;

Bravo, R .

NATURE MEDICINE, 1997, 3 (11) :1285-1289

← 1 2 3 4 →